SCHEMBL3279897

SCHEMBL3279897

Nc1c(Cl)cccc1C(=O)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPT P10636 1/20 0.49
SMO Q99835 1/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.44
ERCC5 P28715 2/20 0.44
FEN1 P39748 2/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
AKR1B1 P15121 2/20 0.42
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
LMNA P02545 1/20 0.41
PIK3CA P42336 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515732 0.84 ERCC5 (0.59) HTTTDP1L3MBTL1MAPTSMO
SCHEMBL8984584 0.83 ERCC5 (0.60) HTTTDP1L3MBTL1MAPTSMO
SCHEMBL10954405 0.83 G6PD (0.52) TDP1L3MBTL1MAPTMEN1KMT2A
SCHEMBL1878465 0.83 KDM4E (0.47) TDP1L3MBTL1MAPTMEN1KMT2A
SCHEMBL9061917 0.81 PIK3CA (0.53) HTTTDP1L3MBTL1MAPTSMO
SCHEMBL3282076 0.80 MAPT (0.49) HTTTDP1L3MBTL1MAPTSMO
SCHEMBL3278890 0.80 SMN1; SMN2 (0.49) MEN1KMT2AERCC5FEN1AKR1B1
SCHEMBL2533018 0.79 ALDH1A1 (0.47) HTTTDP1KMT2AALDH1A1ERCC5
SCHEMBL28041433 0.79 MEN1 (0.43) TDP1L3MBTL1MAPTMEN1KMT2A
SCHEMBL7129795 0.78 MEN1 (0.62) L3MBTL1MAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700595-B2 such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs) WYETH LLC (US) 2010-04-20 US disclosed
EP-1853566-A1 CINNOLINE COMPOUNDS AND THEIR USE AS LIVER X RECEPTOR MODULATORS Wyeth (US) 2007-11-14 EP disclosed
US-20060252757-A1 Cinnoline compounds WYETH 2006-11-09 US disclosed
WO-2006094034-A1 CINNOLINE COMPOUNDS AND THEIR USE AS LIVER X RECEPTOR MODILATORS WYETH (US) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252757-A1 Cinnoline compounds NR1H3, NR1H2, CNR1 HTT 3643/4885TDP1 4009/4885L3MBTL1 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.